http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-111995567-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02P20-55 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D213-69 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P39-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-16 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P39-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D213-69 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-16 |
| filingDate | 2020-07-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2022-11-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2022-11-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-111995567-B |
| titleOfInvention | Carboxamide pyridone-type iron chelator derivatives with potential multi-target anti-AD activity, preparation method and application thereof |
| abstract | The present invention provides carboxamide pyridone iron chelating agent derivatives shown in a kind of formula (I) or formula (II) and its preparation method and application; The carboxamide shown in formula (I) or formula (II) Amidepyridone iron chelator derivatives and pharmaceutically acceptable salts thereof have the ability to inhibit monoamine oxidase, chelate metal iron ions, anti-Aβ and antioxidant activities, and can be used to prepare anti-Alzheimer's disease, anti-Parkinson's disease or pass Drugs that inhibit monoamine oxidase, chelate metal iron ions, anti-Aβ and other diseases treated by anti-oxidation; |
| priorityDate | 2020-07-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 186.